sb 203580 has been researched along with dorsomorphin in 10 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (dorsomorphin) | Trials (dorsomorphin) | Recent Studies (post-2010) (dorsomorphin) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 363 | 1 | 259 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Plowright, AT; Schade, D | 1 |
Caballero, E; García-Cárceles, J; Gil, C; Martínez, A | 1 |
Bartrons, R; Gamell, C; Ortuño, MJ; Rodríguez-Carballo, E; Rosa, JL; Susperregui, AR; Ventura, F | 1 |
Chenge, J; Cok, A; Louters, LL; Oram, DS; Plaisier, C; Salie, MJ | 1 |
Hwang, JK; Jo, K; Lee, SE; Lee, SW | 1 |
Bahn, GH; Cho, KS; Choi, CS; Han, SH; Hur, J; Joo, SH; Kim, KC; Kim, P; Ko, HM; Kwon, KJ; Lee, J; Lee, SH; Park, JH; Ryu, JH; Shin, CY | 1 |
Gao, P; Wang, Y; Wu, X; Zhang, J; Zhang, L | 1 |
2 review(s) available for sb 203580 and dorsomorphin
Article | Year |
---|---|
Medicinal Chemistry Approaches to Heart Regeneration.
Topics: Animals; Cell Differentiation; Cell Proliferation; Cellular Reprogramming; Fibroblasts; Humans; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Pluripotent Stem Cells; Regeneration; Signal Transduction; Stem Cells | 2015 |
Kinase Inhibitors as Underexplored Antiviral Agents.
Topics: Animals; Antiviral Agents; Drug Repositioning; Humans; Protein Kinase Inhibitors; Virus Diseases; Viruses | 2022 |
8 other study(ies) available for sb 203580 and dorsomorphin
Article | Year |
---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Noncanonical BMP signaling regulates cyclooxygenase-2 transcription.
Topics: Animals; Bone Morphogenetic Protein 2; Cell Line; Core Binding Factor Alpha 1 Subunit; Cyclooxygenase 2; Enzyme Inhibitors; Gene Expression Regulation; Imidazoles; Mesenchymal Stem Cells; Mice; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Proto-Oncogene Proteins c-jun; Pyrazoles; Pyridines; Pyrimidines; Regulatory Elements, Transcriptional; Response Elements; Signal Transduction; Skull; Tissue Culture Techniques; Transcription, Genetic | 2011 |
Berberine acutely activates the glucose transport activity of GLUT1.
Topics: AMP-Activated Protein Kinases; Animals; Berberine; Biological Transport; Cell Line; Deoxyglucose; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Flavonoids; Glucose; Glucose Transporter Type 1; Imidazoles; Kinetics; Mice; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Pyrimidines | 2011 |
Prunus yedoensis Matsum. stimulates glucose uptake in L6 rat skeletal muscle cells by activating AMP-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways.
Topics: AMP-Activated Protein Kinases; Animals; Biological Transport; Cell Line; Glucose; Imidazoles; Muscle Fibers, Skeletal; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Prunus; Pyrazoles; Pyridines; Pyrimidines; Rats; Signal Transduction | 2012 |
Glucose deprivation reversibly down-regulates tissue plasminogen activator via proteasomal degradation in rat primary astrocytes.
Topics: Animals; Astrocytes; Blotting, Western; Chromones; Down-Regulation; Glucose; Imidazoles; Morpholines; Proteasome Endopeptidase Complex; Pyrazoles; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tissue Plasminogen Activator | 2013 |
Adiponectin attenuates high glucose-induced apoptosis through the AMPK/p38 MAPK signaling pathway in NRK-52E cells.
Topics: Adiponectin; Animals; Apoptosis; Blotting, Western; Cell Line; Flow Cytometry; Glucose; Imidazoles; Kidney Tubules, Proximal; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Phosphorylation; Pyrazoles; Pyridines; Pyrimidines; Rats; Transcriptome | 2017 |